| イスラエル | トルコ | オーストリア | |
| 腹腔鏡下子宮摘出術 | から $15,800 | から $7,000 | から $15,000 |
| 子宮摘出術 | から $14,500 | から $4,760 | から $15,000 |
| ホルモン療法 | から $3,800 | から $406 | から $7,000 |
| ダヴィンチロボット支援下子宮摘出術 | から $18,500 | から $11,000 | から $16,000 |
| 子宮癌放射線治療 | - | から $4,000 | から $6,967 |
メリムスキー教授は、軟部組織および骨腫瘍学の第一人者であり、スーラスキー医療センターにおける肉腫治療に革新をもたらしました。
Dr. Shira Felder is a senior radiation oncologist. She focuses on gynecologic and urologic cancers. She has advanced expertise in VMAT, IMRT, SBRT, and gynecologic brachytherapy. She delivers precise treatment with fewer side effects.
She heads the Gynecologic Oncology Service at Sheba Medical Center. She is a senior physician in the Radiation Oncology Division. She earned her MD at Hadassah. She completed residency at Sheba and a fellowship in the Radiation Medicine Program at the University of Toronto and Princess Margaret Cancer Centre. She is board-certified in Radiation Oncology. She is a member of ESTRO, the Israeli oncology societies, the CPSO, and the CMA.
Her research covers brachytherapy patient safety. It also includes stereotactic ablative radiotherapy for stage I lung cancer. She has studied treatment delays in cervical cancer. She has examined vitamin D deficiency in oncology patients.
Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.
He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.
He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.
Israel provides safe uterine cancer treatment that meets strict global benchmarks for quality and safety. Facilities like Sourasky and Hadassah maintain JCI accreditation and national certifications. Patients benefit from success rates reaching 90% for early-stage cases and access to Da Vinci robotic surgery.
Bookimed Expert Insight: Israeli oncology centers demonstrate high efficiency by integrating diagnostics and treatment starts within days. Sourasky Medical Center serves over 1.8 million patients annually, showing immense clinical volume. This high throughput ensures surgeons maintain proficiency in complex procedures that general hospitals may handle rarely.
Patient Consensus: Patients note the importance of verifying a surgeon's specific volume of uterine cases before beginning therapy. Many emphasize the need to factor in local security conditions when planning long-term treatment cycles like chemotherapy.
Israel offers advanced staging using transvaginal ultrasound, pelvic MRI, and PET-CT to detect small metastases. Treatment choices include robotic hysterectomy and targeted therapies. Specialized centers like Sourasky Medical Center report 90% oncology success rates. Experts integrate JCI-accredited standards with minimally invasive surgical protocols.
Bookimed Expert Insight: Israeli specialists like Dr. Dan Grisaro and Dr. Rabin Tatiana prioritize multidisciplinary planning for complex cases. Data from Sourasky Medical Center reveals that high-volume centers performing 34,000 annual operations maintain superior safety. Patients should confirm if their surgical team includes a dedicated radiation oncologist for integrated brachytherapy planning.
Patient Consensus: Patients value the direct access to highly experienced professors and feel the level of detail provided during the initial diagnostic phase is exceptional.
Patients typically need 14 to 21 days in Israel for uterine cancer treatment. This timeframe covers precise diagnostic staging, surgical intervention, and mandatory post-operative monitoring. Minimally invasive techniques like robotic surgery often allow for quicker recovery and earlier discharge from the hospital.
Bookimed Expert Insight: While public hospitals have high volumes, private centers like Assuta Medical Center offer a patient-choice model. This allows you to select a specific specialist, such as Prof. Dan Grisaro, to match your surgical needs. Our data shows that coordinating diagnostic tests before arrival can reduce your total stay in Tel Aviv by up to 3 days.
Patient Consensus: Patients note it is important to stay near the clinic for the first week after discharge. They emphasize that having a coordinator manage appointments makes the fast-paced diagnostic schedule much easier to handle.
Specialists evaluate lymph-node status using sentinel lymph node mapping and advanced imaging to avoid full lymphadenectomy. These methods accurately stage uterine cancer while reducing lymphedema risk. Sentinel node biopsy identifies the first draining nodes. It often yields over 95% accuracy in detecting spread.
Bookimed Expert Insight: Israeli oncology centers like Sourasky and Assuta utilize DaVinci robotic platforms for sentinel node identification. This technology allows surgeons to use infrared cameras to see fluorescent tracers in real-time. Dr. Dan Grisaro at Sourasky specifically focuses on these minimally invasive techniques to improve staging precision. Choosing a center with robotic capabilities ensures a more accurate biopsy than traditional open methods.
Patient Consensus: Patients emphasize the importance of molecular profiling and sentinel mapping to avoid long-term swelling. Many recommend asking for intraoperative frozen section analysis to make real-time decisions about nodal removal.
Directly following a laparoscopic hysterectomy, patients generally return home within 1 to 2 days. Most resume daily activities in 2 to 4 weeks. Short flights are possible after 2 weeks, while international travel requires 4 weeks to ensure surgical stability and safety.
Bookimed Expert Insight: Israeli oncology centers like Sourasky and Assuta serve a high volume of international patients, performing thousands of robotic and laparoscopic surgeries annually. Data shows that clinics utilizing DaVinci robotic assistance often report higher precision in uterine cancer cases. If your procedure involves robotic assistance, you may experience less postoperative pain, though the 2-week minimum wait for short-haul flights remains the standard safety protocol to prevent circulation issues.
Patient Consensus: Many patients suggest walking regularly during the first week to help ease gas pain. They also note that wearing compression stockings during the flight back is a practical must for comfort and peace of mind.
Fertility preservation is possible for early-stage endometrial cancer through specialized hormonal therapy and conservative surgery. This approach is typically reserved for Stage IA, Grade 1 tumors confined to the uterine lining. Israel offers high-density oncology expertise and integrated fertility counseling for patient-specific protocols.
Bookimed Expert Insight: Israeli oncology centers like Sourasky (Ichilov) stand out by integrating fertility preservation experts directly into the oncology team. Data shows this multidisciplinary approach is vital because patients often face higher miscarriage rates or underlying conditions like PCOS. Prof. Dan Grisaro at Sourasky specifically focuses on these fertility-sparing protocols, ensuring patients receive simultaneous care for cancer remission and reproductive planning.
Patient Consensus: Patients note that while the process of frequent biopsies every few months is emotionally taxing, it is a necessary step for safety. Many emphasize that egg freezing should be discussed before starting treatment as a proactive backup measure.
Tel Aviv serves as a primary hub for international uterine cancer care. Facilities like Sourasky Medical Center and Assuta Medical Center offer advanced robotic hysterectomy and personalized immunotherapy. These centers maintain Joint Commission International accreditation. Patient success rates for oncology treatments in these Israeli facilities average 90%.
Bookimed Expert Insight: Israeli oncology centers demonstrate high surgical efficiency, with Assuta Medical Center performing over 92,000 operations annually despite having fewer beds than public hospitals. This high volume often leads to more refined surgical techniques for complex gynecologic cases. Patients may find better flexibility in selecting specific senior surgeons at private clinics like Assuta or Herzliya Medical Center compared to large public state institutions.
Patient Consensus: Patients note that Tel Aviv is often easier to navigate than Jerusalem due to higher English proficiency and better hotel options. Many emphasize that choosing a specialist surgeon like those who have trained at MD Anderson or Memorial Sloan Kettering is more important than hospital name alone.